# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-006545
Filing Date
2022-03-17
Accepted
2022-03-17 16:10:35
Documents
135
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | vyne-20211231.htm iXBRL | 10-K | 2268924
2 | EX-3.1 | exhibit31vynecertificateof.htm | EX-3.1 | 91656
3 | EX-4.12 | exhibit412.htm | EX-4.12 | 25308
4 | EX-10.12 | exhibit1012-stuartexecut.htm | EX-10.12 | 56188
5 | EX-10.13 | exhibit1013-zerondaxexec.htm | EX-10.13 | 50412
6 | EX-21.1 | exhibit211listofsubsidiari.htm | EX-21.1 | 3696
7 | EX-23.1 | exhibit231consentus2.htm | EX-23.1 | 2310
8 | EX-31.1 | vyne-20211231xexx311.htm | EX-31.1 | 10830
9 | EX-31.2 | vyne-20211231xexx312.htm | EX-31.2 | 10824
10 | EX-32.1 | vyne-20211231xexx321.htm | EX-32.1 | 6987
11 | EX-32.2 | vyne-20211231xexx322.htm | EX-32.2 | 6954
17 |  | exhibit1012-stuartexecut001.jpg | GRAPHIC | 192884
18 |  | exhibit1012-stuartexecut002.jpg | GRAPHIC | 205990
19 |  | exhibit1012-stuartexecut003.jpg | GRAPHIC | 244178
20 |  | exhibit1012-stuartexecut004.jpg | GRAPHIC | 263532
21 |  | exhibit1012-stuartexecut005.jpg | GRAPHIC | 326927
22 |  | exhibit1012-stuartexecut006.jpg | GRAPHIC | 314266
23 |  | exhibit1012-stuartexecut007.jpg | GRAPHIC | 304061
24 |  | exhibit1012-stuartexecut008.jpg | GRAPHIC | 61058
25 |  | exhibit1012-stuartexecut009.jpg | GRAPHIC | 185994
26 |  | exhibit1012-stuartexecut010.jpg | GRAPHIC | 90962
27 |  | exhibit1012-stuartexecut011.jpg | GRAPHIC | 277495
28 |  | exhibit1012-stuartexecut012.jpg | GRAPHIC | 322902
29 |  | exhibit1012-stuartexecut013.jpg | GRAPHIC | 284055
30 |  | exhibit1012-stuartexecut014.jpg | GRAPHIC | 308222
31 |  | exhibit1012-stuartexecut015.jpg | GRAPHIC | 273381
32 |  | exhibit1012-stuartexecut016.jpg | GRAPHIC | 140242
33 |  | exhibit1012-stuartexecut017.jpg | GRAPHIC | 58167
34 |  | exhibit1013-zerondaxexec001.jpg | GRAPHIC | 263013
35 |  | exhibit1013-zerondaxexec002.jpg | GRAPHIC | 266359
36 |  | exhibit1013-zerondaxexec003.jpg | GRAPHIC | 317657
37 |  | exhibit1013-zerondaxexec004.jpg | GRAPHIC | 308328
38 |  | exhibit1013-zerondaxexec005.jpg | GRAPHIC | 320591
39 |  | exhibit1013-zerondaxexec006.jpg | GRAPHIC | 101916
40 |  | exhibit1013-zerondaxexec007.jpg | GRAPHIC | 178800
41 |  | exhibit1013-zerondaxexec008.jpg | GRAPHIC | 75224
42 |  | exhibit1013-zerondaxexec009.jpg | GRAPHIC | 263788
43 |  | exhibit1013-zerondaxexec010.jpg | GRAPHIC | 335187
44 |  | exhibit1013-zerondaxexec011.jpg | GRAPHIC | 273876
45 |  | exhibit1013-zerondaxexec012.jpg | GRAPHIC | 313481
46 |  | exhibit1013-zerondaxexec013.jpg | GRAPHIC | 278293
47 |  | exhibit1013-zerondaxexec014.jpg | GRAPHIC | 172713
48 |  | exhibit1013-zerondaxexec015.jpg | GRAPHIC | 61291
49 |  | vyne-20211231_g1.jpg | GRAPHIC | 44465
50 |  | vyne-20211231_g2.jpg | GRAPHIC | 36706
| Complete submission text file | 0001628280-22-006545.txt |  | 20072412

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vyne-20211231.xsd | EX-101.SCH | 63174
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vyne-20211231_cal.xml | EX-101.CAL | 92931
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vyne-20211231_def.xml | EX-101.DEF | 343966
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vyne-20211231_lab.xml | EX-101.LAB | 810123
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vyne-20211231_pre.xml | EX-101.PRE | 568431
129 | EXTRACTED XBRL INSTANCE DOCUMENT | vyne-20211231_htm.xml | XML | 1219339

Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38356 | Film No.: 22748607
SIC: 2834 Pharmaceutical Preparations